Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Protocol # WA25046: A Phase III, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis"
Cohen, Bruce Arnold
(PD/PI)
Neurology
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
4/19/12
→
4/19/15
Funding
PPD Development
(WA25046)
Genentech, Inc.
(WA25046)
View all
View less